From the FDA Drug Label
INDICATIONS AND USAGE This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
- Administration: BPC-157 is administered parenterally, which means it is given by injection, and can be administered via intravenous, intramuscular, or subcutaneous routes.
- Key Point: The drug label indicates that BPC-157 is used for diluting or dissolving other drugs for injection, but does not provide information on its therapeutic use or dosage.
- Therapeutic Use: The label does not explicitly state the therapeutic use of BPC-157, only its use as a diluent or solvent for other drugs 1.
From the Research
BPC-157 is a synthetic peptide that has shown potential in promoting tissue healing, reducing inflammation, and supporting recovery from injuries, but its use should be approached with caution due to the lack of FDA approval and limited human clinical trials, and it is recommended to consult with a healthcare provider before considering its use 2.
Administration and Dosage
BPC-157 can be administered through subcutaneous injection or orally, with common dosages in research settings ranging from 200-500 micrograms once or twice daily, and treatment courses lasting 2-4 weeks 3.
Mechanism of Action
The peptide appears to work by accelerating the formation of blood vessels (angiogenesis), modulating growth factors, and reducing inflammatory markers, which can lead to improved vascular integrity and immune response 4.
Potential Benefits and Risks
BPC-157 has been studied for its potential benefits in various medical conditions, including tissue injury, inflammatory bowel disease, and CNS disorders, and has shown promise in reducing inflammation and promoting healing 2. However, its long-term effects remain largely unknown, and its quality and purity can vary significantly between suppliers, which can lead to risks including improper dosing, contamination, and potential unknown side effects 5.
Clinical Use
While BPC-157 has not been approved for use in standard medicine by the FDA and other global regulatory authorities, it has been offered for sale on many websites, and some studies have suggested its potential as a treatment for various conditions, including knee pain and COVID-19 3, 4.
Recommendation
Given the limited human clinical trials and lack of FDA approval, it is recommended to approach the use of BPC-157 with caution and to consult with a healthcare provider before considering its use, as self-administration carries risks including improper dosing, contamination, and potential unknown side effects 2.